As patents expire, prescription drug prices will plummet

Generic versions of big-selling drugs for blood pressure, asthma, diabetes, depression, high triglycerides, HIV and bipolar disorder also are coming by then. The flood of generics will continue for the next decade or so, as about 120 brand-name ...
Click on the link to read the full article at Detroit Free Press

Avoid Methylene Blue or Linezolid With Serotonergics

Physicians generally should avoid prescribing either methylene blue or linezolid (Zyvox,Pfizer) in combination with serotonergic agents such as paroxetine or duloxetine to avoid a potential drug interaction causing a dangerous condition called serotonin syndrome, the US Food and Drug Administration (FDA) announced today.
Linezolid is an antibacterial agent, and methylene blue is a dye used in diagnostic procedures and in the treatment of conditions ranging from methemoglobinemia to cyanide poisoning.

Energy drinks are a health risk, says CSE study

Energy drinks consumed to increase stamina do more harm to health than good and can lead to addiction to alcohol, a study released by NGO Centre for Science and Environment said. The CSE had tested two samples each of eight popular energy brands sold in India and found 44 % of the samples breached the safety limit of 145 particles per million (ppm) of caffeine prescribed under the Prevention of Food Adulteration Act, 1954.
Caffeine is a psycho-stimulant and can lead to seizure, strokes and even death.

Clinical trials: DCGI faults 9 more CROs

Nearly a month after the licence of Axis Clinicals was suspended for irregularities in conducting trials on poor illiterate women, officials of the Drug Controller General of India (DCGI) found similar violations by nine Clinical Research Organizations (CROs) in the state. Highly-placed sources said that there are glaring violations in the recruitment process of `subjects' and in taking their informed consent in almost all these organizations, where the gullible are becoming guinea pigs.